Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Meds
Feb 28, 2008

I have been taking combination therapy drugs for 8 years now. I have heard about Atripla. Any reason to not switch, for the convenience of one pill a day?

Response from Dr. Young

It's always understandable that one would want to switch to simple, once-daily treatments. The real issue about switching to tenofovir/FTC/efavirenz (Atripla or Truvada+Sustiva) is whether there is any reason to suspect that these medications are not ideal for you.

This means understanding your risks of having drug resistance, kidney disease or intolerance of efavirenz (at the very least). Any switch in successful medications should be undertaken with a full understanding of the potential benefits and risks of the switch- this means having a thoughtful discussion with your healthcare provider about your concerns and unmet needs of your current (successful) treatment regimen.

I hope this helps. BY



Previous
Vitamins
Next
Can Vitamins Help?

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement